combination therapy

Open Access
Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer
MOTOKAZU SATO, QINGHONG HAN, YUTARO KUBOTA, ANTON BARANOV, DANIEL ARDJMAND, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, MICHAEL BOUVET, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN

Anticancer Research January 2024, 44 (1) 31-35; DOI: https://doi.org/10.21873/anticanres.16785
You have access
Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors
YU JIN KIM, SE-KYEONG JANG, GYEONGMI KIM, SUNG-EUN HONG, CHAN SUB PARK, MIN-KI SEONG, HYUN-AH KIM, KWANG SEOK KIM, CHUN-HO KIM, KI SOO PARK, JUNGIL HONG, HYEON-OK JIN and IN-CHUL PARK

Anticancer Research May 2023, 43 (5) 1973-1980; DOI: https://doi.org/10.21873/anticanres.16357
Open Access
Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction
YUTARO KUBOTA, QINGHONG HAN, NORIYUKI MASAKI, CHIHIRO HOZUMI, KAZUYUKI HAMADA, YUSUKE AOKI, KOYA OBARA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

Anticancer Research December 2022, 42 (12) 5819-5823; DOI: https://doi.org/10.21873/anticanres.16089
Open Access
Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model
NORIYUKI MASAKI, QINGHONG HAN, CARISSA SAMONTE, NATHANIEL F. WU, CHIHIRO HOZUMI, JUSTIN WU, KOYA OBARA, YUTARO KUBOTA, YUSUKE AOKI, MICHAEL BOUVET and ROBERT M. HOFFMAN

Anticancer Research November 2022, 42 (11) 5217-5222; DOI: https://doi.org/10.21873/anticanres.16028
Open Access
Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease
YUTARO KUBOTA, QINGHONG HAN, CHIHIRO HOZUMI, NORIYUKI MASAKI, JUN YAMAMOTO, YUSUKE AOKI, TAKUYA TSUNODA and ROBERT M. HOFFMAN

Anticancer Research May 2022, 42 (5) 2567-2572; DOI: https://doi.org/10.21873/anticanres.15734
You have access
Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
YUSUKE AOKI, YASUNORI TOME, QINGHONG HAN, JUN YAMAMOTO, KAZUYUKI HAMADA, NORIYUKI MASAKI, YUTARO KUBOTA, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research February 2022, 42 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.15531
You have access
A Multicentre Retrospective Study of Nivolumab Plus Ipilimumab for Untreated Metastatic Renal Cell Carcinoma
RENPEI KATO, TAKAHIRO KOJIMA, TOMOKAZU SAZUKA, HAYATO YAMAMOTO, SHOHEI FUKUDA, KAZUTOSHI YAMANA, YUSUKE SUGINO, SHUZO HAMAMOTO, NOBORU NAKAIGAWA, KOKI KABU, HIROSHI MURAKAMI and WATARU OBARA

Anticancer Research December 2021, 41 (12) 6199-6209; DOI: https://doi.org/10.21873/anticanres.15439
You have access
Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10
KATHRINE S. RALLIS, AMBER E. CORRIGAN, HASHIM DADAH, ALAN MATHEW GEORGE, SUMIRAT M. KESHWARA, MICHAIL SIDERIS and BERNADETT SZABADOS

Anticancer Research July 2021, 41 (7) 3247-3252; DOI: https://doi.org/10.21873/anticanres.15110
Open Access
Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
YUSUKE AOKI, YASUNORI TOME, NATHANIEL F. WU, JUN YAMAMOTO, KAZUYUKI HAMADA, QINGHONG HAN, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research April 2021, 41 (4) 1745-1751; DOI: https://doi.org/10.21873/anticanres.14939
You have access
Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia
HYO JEONG KIM, HWANI RYU, HYUN-KYUNG CHOI, JIE-YOUNG SONG, SANG-GU HWANG and JIYEON AHN

Anticancer Research February 2021, 41 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.14824

Main menu

User menu

Search

combination therapy

Pages